Therapy using erythropoietin receptor agonist

Therapy using erythropoietin receptor agonist (procedure)

procedure
£1.00

Supplier: international · SCTID 1156741008

Found in

Hormone therapy

Related products

Ablative hormone therapy
£1.00
Administration of prophylactic combined calcium and vitamin D3 preparation
£1.00
Androgen deprivation therapy
£1.00
Basal insulin regime
£1.00
Basal-bolus insulin regime
£1.00
Basal-plus preprandial insulin regime
£1.00
Controlled ovarian stimulation
£1.00
Hormone manipulation
£1.00
Hormone replacement therapy
£1.00
Initiation of first time insulin therapy
£1.00
Internal iliac artery vasopressin infusion
£1.00
Intramuscular calcitonin therapy
£1.00
Intramuscular hormone therapy
£1.00
Intravenous hydrocortisone therapy
£1.00
Leuprorelin therapy
£1.00
Levothyroxine therapy
£1.00
Methylprednisolone pulse therapy
£1.00
Neoadjuvant endocrine therapy
£1.00
Non-ablative hormone therapy
£1.00
Ovulation induction
£1.00
Parathyroid hormone therapy
£1.00
Premixed insulin regime
£1.00
R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy
£1.00
R-CHOP chemotherapy regimen
£1.00
Basket
Total£0.00